In addition, TSG can reduce the formation of NLRP3 inflammatory vesicles by inhibiting the activation of the cGAS-STING pathway, thereby reducing the neuroinflammatory response and demonstrating its potential therapeutic value in Alzheimer’s disease (164). Here, CGAS is linked to Alzheimer disease.